You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
益盛藥業(002566.SZ):擬設立孫公司益盛漢參生物科技(上海) 帶動人蔘製品及相關產品銷售
格隆匯 01-12 16:46

格隆匯 1 月 12日丨益盛藥業(002566.SZ)公佈,2021年1月12日,公司第七屆董事會第十一次會議審議並通過了《關於控股子公司對外投資設立孫公司的議案》,根據公司經營發展需要,同意控股子公司益盛新零售(杭州)有限公司(“益盛新零售”)同上海卉茂生物科技集團有限公司(“卉茂生物”)合作設立孫公司益盛漢參生物科技(上海)有限公司(暫定名,以市場監督管理部門登記為準)。孫公司註冊資本為100萬元,其中益盛新零售出資51萬元,佔註冊資本的51%;卉茂生物出資49萬元,佔註冊資本的49%。

此次對外投資設立益盛漢參生物科技(上海)有限公司是基於公司戰略規劃和經營發展的需要,可進一步延伸公司的產業鏈,帶動人蔘製品及相關產品的銷售,有利於增強企業的核心競爭力,提升公司品牌形象,為股東創造價值,符合公司的長遠發展戰略。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account